Location History:
- Bethel, CT (US) (2021)
- Philadelphia, PA (US) (2023)
Company Filing History:
Years Active: 2021-2023
Title: Danlin Yang: Innovator in Cancer Treatment
Introduction
Danlin Yang is a prominent inventor based in Bethel, CT (US), known for his significant contributions to the field of cancer treatment. With a focus on developing novel antibody molecules, Yang has made strides in therapeutic applications that aim to combat cancer diseases. His work is characterized by innovation and a commitment to improving patient outcomes.
Latest Patents
Yang holds 2 patents related to his groundbreaking research. His latest patents involve the development of antibody molecules targeting PD1 and LAG3, which are crucial in cancer treatment. These inventions encompass nucleic acids encoding such antibody molecules, methods for their preparation, and host cells capable of expressing these antibodies. The compositions derived from these antibodies are intended for therapeutic purposes, particularly in the treatment of various cancer diseases.
Career Highlights
Danlin Yang is currently associated with Boehringer Ingelheim International GmbH, where he continues to advance his research in the field of oncology. His work has garnered attention for its potential to revolutionize cancer therapies and improve the lives of patients battling this disease.
Collaborations
Yang collaborates with esteemed colleagues such as Markus Zettl and Ivo Lorenz, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Danlin Yang's contributions to cancer treatment through his innovative antibody molecules highlight his role as a leading inventor in the field. His ongoing research and collaborations promise to pave the way for new therapeutic options in oncology.